J Korean Med Assoc.  2006 Jun;49(6):515-530. 10.5124/jkma.2006.49.6.515.

Screening for Early Detection of Cancers II

• Seo HG

• KMID: 2137832
• DOI: http://doi.org/10.5124/jkma.2006.49.6.515

Abstract

This paper will review the recent recommendations for screening of 6 major cancers in Korea; stomach cancer, lung cancer, liver cancer, colon cancer, breast cancer, and cervical cancer. Gastrofiberscopy and UGIS remain the main screening tool for stomach cancer over 40 years of age. There is no recommendation for lung cancer screening. Ultrasonography and alpha-fetoprotein can be recommended for high risk group of liver cancer. Colonoscopy every 5~10 years over 50 is recommended for early detection of colon cancer. Flexible sigmoidoscopy plus double contrast barium enema every 5~10 years can be an alternative for it. Mammography is the main screening tool for breast cancer over 50. Pap smear is recommended for screening for cervical cancer 3 years after vaginal sex. Evidence-based screening programs for major cancers are needed in Korea.

Keyword

Cancer screening; Stomach cancer; Liver cancer; Lung cancer; Colon cancer; Breast cancer; Cervix cancer

MeSH Terms

alpha-Fetoproteins
Barium
Breast Neoplasms
Colonic Neoplasms
Colonoscopy
Early Detection of Cancer
Enema
Korea
Liver Neoplasms
Lung Neoplasms
Mammography
Mass Screening*
Sigmoidoscopy
Stomach Neoplasms
Ultrasonography
Uterine Cervical Neoplasms
Barium
alpha-Fetoproteins

Reference

1. Matsukuma A, Furusawa M, Tomoda H, Seo Y. A clinicopathological study of asymptomatic gastric cancer. British Journal of Cancer. 1996. 74:1647–1650.

2. Hanazaki K, Sodeyama H, Wakabayashi M, Miyazawa M, Yokoyama S, Ohtsuka M, et al. Surgical treatment of gastric cancer detected by mass screening. Hepatogastenterology. 1997. 44:1126–1132.

5. Hovinen E, Kekki M, Kuikka S. A theory to the stochastic dynamic model building for chronic progressive disease processes with an application to chronic gastritis. J Theor Biol. 1976. 57:131–152.

6. Fujita S. Sugimura J, Yamanura Y, editors. Kinetics of cancer cell proliferation and cancer growth. Modern biological sciences. 1970. 15th ed. Tokyo: Iwanami;248–261.

7. Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long-term follow up study. Gut. 2000. 47:618–621.

8. Shiratori Y, Nakagawa S, Kikuchi A, et al. Significance of gastric mass screening survey. Am J Gastroenterol. 1985. 80:831–834.

11. Jemal A, Tiwari RC, Murray T, Chafoor A, Samuels A, Thun MJ, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004. 54:8–29.

12. Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR. Early lung cancer detection: results of the initial(Prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984. 130:549–554.

13. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984. 86:44–45.

14. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Uhlenhopp MA, et al. Early lung cancer detection results of the initial(Prevalence) radiological and cytological screening in the Mayo Clinic study. Am Rev Respir Dis. 1984. 130:561–565.

15. Kubic A, Pllak J. Lung cancer detection. results of a randomized prospective study in Czechoslovakia. Cancer. 1986. 57:2427–2437.

16. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Yamanda T, et al. Results of three-year mass screening programme for lung cancer using low-dose spiral computed tomography scanner. Br J Cancer. 2001. 84:25–32.

17. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Smith JP, et al. Early lung cancer action project: overall design findings from baseline screening. Lancet. 1999. 354:99–105.

18. Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003. 226:756–761.

19. Pastorino U, Bellomi M, Landoni C, De Fiori ED, Arnaldi P, Fazio F, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet. 2003. 362:593–597.

20. Yankelevitz D. CT screening for lung cancer. Am J Roentgenol. 2003. 180:1736–1737.

21. Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Mietrinen OS, et al. CT screening for lung Cancer: suspiciousness of nodules according to size on baseline scans. Radiology. 2004. 231:164–168.

22. Libby DM, Smigh JP, Altorki NK, Pasmantier MW, Yankelevitz D, Henschke CI. Managing the small pulmonary nodule discovered by CT. Chest. 2004. 125:1522–1529.

23. Chong SM, Lee KS, Chung MJ, Kim TS, Kim HJ, Kwon OJ, et al. Lung cancer screening with low-dose helical CT in Korea: experiences at Samsung Medical Center. J Korean Med Sci. 2005. 20:402–408.

24. Ahn MI. Lung cancer screening with low-dose chest CT: current issues. Cancer Research and Treatment. 2004. 36:163–166.

25. Sakuma K, Saitoh N, Kasai M, et al. Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B S and e antigen/antibody in serum: a prospective study. Hepatology. 1988. 8:1642–1646.

26. Beasley RP. Hepatitis B virus. Cancer. 1988. 61:1942–1956.

27. Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. American Journal of Medicine. 1996. 171:422–434.

28. Wun YT, Dickinson JA. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2003. CD002799.

29. Chen JG, Parkin DM, Chen QG, Lu JH, Shen QJ, Zhu YR, et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen. 2003. 10:204–209.

30. Pateron D, Ganne N, Trinchet JC, Autousseau MH, Mal F, Beaugrand M, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. Journal of Hepatology. 1994. 20:65–71.

31. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of Hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology. 1995. 22:432–438.

32. Tanaka S, Kitamura T, Nakanishi K, Okuda S, Yamazaki H, Fujimoto I, et al. Effectiveness of periodic chekup by ultrasonography for the early diagnosis of hepatoellular carcinoma. Cancer. 1990. 66:2210–2214.

33. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Wang TH, et al. Early detection of hepatocellular carcinoma by real-time Ultrasonography. A prospective study. Cancer. 1985. 56:660–666.

34. Oka H, Tamori A, Kuroki T, et al. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. 1994. 19:61–66.

36. Daniele B, Bencivenga A, Megna AS, Tinessa V. α-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology. 2004. 127:S108–S112.

37. Zhang B, Yang B. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen. 1999. 6:108–110.

39. Sung JL, Chen DS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1985. 89:259–266.

42. Dachman AH, Glick S, Yoshida H. Computed tomography colonography and colon cancer screening. Semin Roentgenol. 2003. 38:54–64.

43. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993. 328:1365–1371.

44. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal occult-blood test. Lancet. 1996. 348:1467–1471.

45. Hardcastel JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Rondomised controlled trial of faecal occult-blood screening for colorectal cancer. Lancet. 1996. 348:1472–1477.

46. Lieberman DA, Weiss DG. Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001. 345:555–560.

48. Church JM. Endoscopy of the colon, rectum, and anus. New York-Tokyo: Igaku-Shoin.

50. Fletcher SW, Elmore JG. Clinical practice: mammographic screening for breast cancer. N Engl J Med. 2003. 348:1672–1680.

51. Irwig L, Houssami N, van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer. 2004. 90:2118–2122.

52. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005. 353:1773–1783.

54. Oster AG. Natural history of cervical intraepithelial neoplasia-a critical review. Int J Gynecol Pathol. 1993. 12:186–192.

55. Michalas SP. The pap test: George N. Papanicolaou (1883~1962): A screening test for the prevention of cancer of uterine cervix. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2000. 90:135–138.

56. Sasieni PD, Cuzick J, Lynch-Farmery E. The National Co-ordinating Network of Cervical Screening Working Group. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer. 1996. 73:1001–1005.

58. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Matchar DB, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000. 132:810–819.

59. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst. 1999. 91:506–511.

60. Davies P, Arbyn M, Dillner J, Kitchener HC, Meijer C, Matti H, et al. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer. 2006. 118:791–796.

61. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000. 96:219–223.

62. Michalas SP. The pap test: George N. Papanicolaou (1883~1962): A screening test for the prevention of cancer of uterine cervix. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2000. 90:135–138.